The variation in the rs1829346 sequence may create a new binding site for miR-1304 (Supplementary Table S3), inhibiting the expression of TUSC7, regulating cell proliferation proteins and ultimately leading to a higher risk of CRT-induced dermatitis. The gene discussed is TUSC7; the disease is skin disorder.